BREAST CANCER FEMALE
Clinical trials for BREAST CANCER FEMALE explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER FEMALE trials appear
Sign up with your email to follow new studies for BREAST CANCER FEMALE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo trial for aggressive breast cancer halted early
Disease control TerminatedThis study tested a new drug called azenosertib combined with two standard cancer drugs (carboplatin and pembrolizumab) in people with metastatic triple-negative breast cancer. The goal was to find the safest dose and see if the combination could shrink tumors. Only 7 people took…
Matched conditions: BREAST CANCER FEMALE
Phase: PHASE1, PHASE2 • Sponsor: Filipa Lynce, MD • Aim: Disease control
Last updated May 26, 2026 03:17 UTC
-
Botswana study probes tamoxifen dropout in breast cancer patients
Knowledge-focused TerminatedThis study looked at why women with breast cancer in Botswana may stop taking tamoxifen, a key hormone therapy. Researchers focused on side effects, quality of life, and HIV status. The study planned to enroll 10 women but was ended early. Findings may help improve adherence in s…
Matched conditions: BREAST CANCER FEMALE
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 26, 2026 03:15 UTC